Publications by authors named "Manon Reda"

Claim this Profile
P
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.
Sylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, Manon Reda, Isabelle Desmoulins

NPJ Breast Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry.
Sylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, Isabelle Desmoulins, Didier Mayeur, Manon Reda

Breast· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variants.
Soha Sewani, Mahshid S Azamian, Bryce A Mendelsohn, Frederic Tran Mau-Them, Manon Réda

Am J Med Genet A· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations.
Laurence Faivre, Jean-Charles Crépin, Manon Réda, Sophie Nambot, Virginie Carmignac

Clin Genet· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients.
Benoit Mazel, Geoffrey Bertolone, Amandine Baurand, Elodie Cosset, Caroline Sawka

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.
Manon Réda, Anaïs Fouquier, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai

Breast· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Manon Reda

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of relevant pharmacogenetic information through exome sequencing in oncology.
Simon Verdez, Juliette Albuisson, Yannis Duffourd, Romain Boidot, Manon Reda

Pharmacogenomics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
Manon Reda, Pauline Macaire, Hélène Bellio, Lionel Uwer, Silvia Ilie

Cancer Chemother Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation and use of whole exome sequencing for metastatic solid cancer.
Manon Réda, Corentin Richard, Aurelie Bertaut, Julie Niogret, Thomas Collot

EBioMedicine· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.
Fanny Ledys, Valentin Derangère, Manon Réda, Jean-Florian Guion, Romily Milliex

Adv Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis